Skip to main content
Top
Published in: Osteoporosis International 11/2011

01-11-2011 | Original Article

Changes in first hip fracture rates in British Columbia Canada, 1990–2004

Authors: K. A. Lefaivre, A. R. Levy, B. Sobolev, S. Y. Cheng, L. Kuramoto, P. Guy

Published in: Osteoporosis International | Issue 11/2011

Login to get access

Abstract

Summary

We determined age-standardized first hip fracture rates in British Columbia between 1990 and 2004. We found sex and fracture type rates in keeping with previous reports and that fracture rates have decreased approximately 18% overall in both men and women.

Introduction

To determine whether there have been changes in the age-, sex-, and subtype-specific first hip fracture rates in Canadian province of British Columbia (BC) between 1990 and 2004.

Methods

Records of all persons aged 60 years and older hospitalized with hip fractures in BC between 1985 and 2004 were obtained from the Canadian Institute for Health Information Discharge Abstract Database. Only the first hip fracture records were included, and fractures likely due to causes other than trauma were excluded. Age- and sex-specific rates were calculated using population denominators from Statistics Canada and direct standardization was used. Age-standardized rates allowed for comparison across years with adjustment for age distribution.

Results

There were 41,990 records of first hip fracture included, and 73% were in women. Trends in age-specific rates by fracture type were similar to previous reports. Between 1990 and 2004, there has been an age-adjusted 18% decrease in first hip fracture rates in women, and 19% decrease in first hip fracture rates in men. The decrease was statistically significant in femoral neck fractures in women, but not in men.

Conclusions

There has been a decrease in age-adjusted hip fracture rates in BC between 1990 and 2004, which is in contrast to previous projections for hip fracture rates in Canada.
Literature
1.
go back to reference Chrischilles E, Shireman T, Wallace R (1994) Costs and health effects of osteoporotic fractures. Bone 15:377–386PubMedCrossRef Chrischilles E, Shireman T, Wallace R (1994) Costs and health effects of osteoporotic fractures. Bone 15:377–386PubMedCrossRef
2.
go back to reference Lorrain J, Paiement G, Chevrier N, Lalumiere G, Laflamme GH, Caron P, Fillion A (2003) Population demographics and socioeconomic impact of osteoporotic fractures in Canada. Menopause 10:228–234PubMedCrossRef Lorrain J, Paiement G, Chevrier N, Lalumiere G, Laflamme GH, Caron P, Fillion A (2003) Population demographics and socioeconomic impact of osteoporotic fractures in Canada. Menopause 10:228–234PubMedCrossRef
3.
go back to reference Randell AG, Nguyen TV, Bhalerao N, Silverman SL, Sambrook PN, Eisman JA (2000) Deterioration in quality of life following hip fracture: a prospective study. Osteoporos Int 11:460–466PubMedCrossRef Randell AG, Nguyen TV, Bhalerao N, Silverman SL, Sambrook PN, Eisman JA (2000) Deterioration in quality of life following hip fracture: a prospective study. Osteoporos Int 11:460–466PubMedCrossRef
4.
go back to reference Papadimitropoulos EA, Coyte PC, Josse RG, Greenwood CE (1997) Current and projected rates of hip fracture in Canada. CMAJ 157:1357–1363PubMed Papadimitropoulos EA, Coyte PC, Josse RG, Greenwood CE (1997) Current and projected rates of hip fracture in Canada. CMAJ 157:1357–1363PubMed
5.
go back to reference Jaglal SB, Sherry PG, Schatzker J (1996) The impact and consequences of hip fracture in Ontario. Can J Surg 39:105–111PubMed Jaglal SB, Sherry PG, Schatzker J (1996) The impact and consequences of hip fracture in Ontario. Can J Surg 39:105–111PubMed
6.
go back to reference Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos Int 7:407–413PubMedCrossRef Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos Int 7:407–413PubMedCrossRef
7.
go back to reference Kannus P, Parkkari J, Sievanen H, Heinonen A, Vuori I, Jarvinen M (1996) Epidemiology of hip fractures. Bone 18:57S–63SPubMedCrossRef Kannus P, Parkkari J, Sievanen H, Heinonen A, Vuori I, Jarvinen M (1996) Epidemiology of hip fractures. Bone 18:57S–63SPubMedCrossRef
8.
go back to reference Levy AR, Mayo NE, Grimard G (1995) Rates of transcervical and pertrochanteric hip fractures in the province of Quebec, Canada, 1981–1992. Am J Epidemiol 142:428–436PubMed Levy AR, Mayo NE, Grimard G (1995) Rates of transcervical and pertrochanteric hip fractures in the province of Quebec, Canada, 1981–1992. Am J Epidemiol 142:428–436PubMed
9.
go back to reference Lofman O, Berglund K, Larsson L, Toss G (2002) Changes in hip fracture epidemiology: redistribution between ages, genders and fracture types. Osteoporos Int 13:18–25PubMedCrossRef Lofman O, Berglund K, Larsson L, Toss G (2002) Changes in hip fracture epidemiology: redistribution between ages, genders and fracture types. Osteoporos Int 13:18–25PubMedCrossRef
10.
go back to reference Levy AR, Mayo NE, Grimard G (1996) Re: “Heterogeneity of hip fracture: age, race, sex, and geographic patterns of femoral neck and trochanteric fractures among the US elderly”. Am J Epidemiol 144:801–803PubMed Levy AR, Mayo NE, Grimard G (1996) Re: “Heterogeneity of hip fracture: age, race, sex, and geographic patterns of femoral neck and trochanteric fractures among the US elderly”. Am J Epidemiol 144:801–803PubMed
11.
go back to reference Giversen IM (2006) Time trends of age-adjusted incidence rates of first hip fractures: a register-based study among older people in Viborg County, Denmark, 1987–1997. Osteoporos Int 17:552–564PubMedCrossRef Giversen IM (2006) Time trends of age-adjusted incidence rates of first hip fractures: a register-based study among older people in Viborg County, Denmark, 1987–1997. Osteoporos Int 17:552–564PubMedCrossRef
12.
go back to reference Kannus P, Niemi S, Parkkari J, Palvanen M, Vuori I, Jarvinen M (1999) Hip fractures in Finland between 1970 and 1997 and predictions for the future. Lancet 353:802–805PubMedCrossRef Kannus P, Niemi S, Parkkari J, Palvanen M, Vuori I, Jarvinen M (1999) Hip fractures in Finland between 1970 and 1997 and predictions for the future. Lancet 353:802–805PubMedCrossRef
13.
go back to reference Spector TD, Cooper C, Lewis AF (1990) Trends in admissions for hip fracture in England and Wales, 1968–85. BMJ 300:1173–1174PubMedCrossRef Spector TD, Cooper C, Lewis AF (1990) Trends in admissions for hip fracture in England and Wales, 1968–85. BMJ 300:1173–1174PubMedCrossRef
14.
go back to reference Hedlund R, Lindgren U, Ahlbom A (1987) Age- and sex-specific incidence of femoral neck and trochanteric fractures. An analysis based on 20,538 fractures in Stockholm County, Sweden, 1972–1981. Clin Orthop Relat Res 132–139 Hedlund R, Lindgren U, Ahlbom A (1987) Age- and sex-specific incidence of femoral neck and trochanteric fractures. An analysis based on 20,538 fractures in Stockholm County, Sweden, 1972–1981. Clin Orthop Relat Res 132–139
15.
go back to reference Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture intervention Trial research group. Lancet 348:1535–1541PubMedCrossRef Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture intervention Trial research group. Lancet 348:1535–1541PubMedCrossRef
16.
go back to reference Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral efficacy with risedronate therapy (VERT) study group. JAMA 282:1344–1352PubMedCrossRef Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral efficacy with risedronate therapy (VERT) study group. JAMA 282:1344–1352PubMedCrossRef
17.
go back to reference Pols HA, Felsenberg D, Hanley DA, Stepan J, Munoz-Torres M, Wilkin TJ, Qin-sheng G, Galich AM, Vandormael K, Yates AJ, Stych B (1999) Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax international trial study group. Osteoporos Int 9:461–468PubMedCrossRef Pols HA, Felsenberg D, Hanley DA, Stepan J, Munoz-Torres M, Wilkin TJ, Qin-sheng G, Galich AM, Vandormael K, Yates AJ, Stych B (1999) Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax international trial study group. Osteoporos Int 9:461–468PubMedCrossRef
18.
go back to reference Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with risedronate therapy (VERT) study group. Osteoporos Int 11:83–91PubMedCrossRef Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with risedronate therapy (VERT) study group. Osteoporos Int 11:83–91PubMedCrossRef
19.
go back to reference Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papaioannou A, Robinson V, Shea B, Wells G, Guyatt G (2002) Meta-analyses of therapies for postmenopausal osteoporosis: III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev 23:517–523PubMedCrossRef Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papaioannou A, Robinson V, Shea B, Wells G, Guyatt G (2002) Meta-analyses of therapies for postmenopausal osteoporosis: III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev 23:517–523PubMedCrossRef
20.
go back to reference Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, Black D, Adachi J, Shea B, Tugwell P, Guyatt G (2002) Meta-analyses of therapies for postmenopausal osteoporosis: II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23:508–516PubMedCrossRef Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, Black D, Adachi J, Shea B, Tugwell P, Guyatt G (2002) Meta-analyses of therapies for postmenopausal osteoporosis: II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23:508–516PubMedCrossRef
21.
go back to reference Jaglal SB, Weller I, Mamdani M, Hawker G, Kreder H, Jaakkimainen L, Adachi JD (2005) Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong? J Bone Miner Res 20:898–905PubMedCrossRef Jaglal SB, Weller I, Mamdani M, Hawker G, Kreder H, Jaakkimainen L, Adachi JD (2005) Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong? J Bone Miner Res 20:898–905PubMedCrossRef
22.
go back to reference Wallace LS, Ballard JE (2003) Osteoporosis coverage in selected women’s magazines and newspapers, 1998-2001. Am J Health Behav 27:75–83PubMed Wallace LS, Ballard JE (2003) Osteoporosis coverage in selected women’s magazines and newspapers, 1998-2001. Am J Health Behav 27:75–83PubMed
23.
go back to reference Fisher AA, O’Brien ED, Davis MW (2009) Trends in hip fracture epidemiology in Australia: possible impact of bisphosphonates and hormone replacement therapy. Bone 45:246–253PubMedCrossRef Fisher AA, O’Brien ED, Davis MW (2009) Trends in hip fracture epidemiology in Australia: possible impact of bisphosphonates and hormone replacement therapy. Bone 45:246–253PubMedCrossRef
24.
go back to reference Kannus P, Niemi S, Parkkari J, Palvanen M, Vuori I, Jarvinen M (2006) Nationwide decline in incidence of hip fracture. J Bone Miner Res 21:1836–1838PubMedCrossRef Kannus P, Niemi S, Parkkari J, Palvanen M, Vuori I, Jarvinen M (2006) Nationwide decline in incidence of hip fracture. J Bone Miner Res 21:1836–1838PubMedCrossRef
25.
go back to reference Boonen S, Orwoll ES, Wenderoth D, Stoner KJ, Eusebio R, Delmas PD (2009) Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study. J Bone Miner Res 24:719–725PubMedCrossRef Boonen S, Orwoll ES, Wenderoth D, Stoner KJ, Eusebio R, Delmas PD (2009) Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study. J Bone Miner Res 24:719–725PubMedCrossRef
26.
go back to reference Orwoll ES (2003) Men, bone and estrogen: unresolved issues. Osteoporos Int 14:93–98PubMed Orwoll ES (2003) Men, bone and estrogen: unresolved issues. Osteoporos Int 14:93–98PubMed
27.
go back to reference Sato Y, Iwamoto J, Kanoko T, Satoh K (2005) Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med 165:1743–1748PubMedCrossRef Sato Y, Iwamoto J, Kanoko T, Satoh K (2005) Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med 165:1743–1748PubMedCrossRef
28.
go back to reference Devold HM, Doung GM, Tverdal A, Furu K, Meyer HE, Falch JA, Sogaard AJ (2010) Prescription of anti-osteoporosis drugs during 2004–2007—a nationwide register study in Norway. Eur J Clin Pharmacol 66:299–306PubMedCrossRef Devold HM, Doung GM, Tverdal A, Furu K, Meyer HE, Falch JA, Sogaard AJ (2010) Prescription of anti-osteoporosis drugs during 2004–2007—a nationwide register study in Norway. Eur J Clin Pharmacol 66:299–306PubMedCrossRef
29.
go back to reference Davis JC, Robertson MC, Ashe MC, Liu-Ambrose T, Khan KM, Marra CA (2010) International comparison of cost of falls in older adults living in the community: a systematic review. Osteoporos Int 21:1295–1306PubMedCrossRef Davis JC, Robertson MC, Ashe MC, Liu-Ambrose T, Khan KM, Marra CA (2010) International comparison of cost of falls in older adults living in the community: a systematic review. Osteoporos Int 21:1295–1306PubMedCrossRef
30.
go back to reference Davis JC, Robertson MC, Ashe MC, Liu-Ambrose T, Khan KM, Marra CA (2010) Does a home-based strength and balance programme in people aged > or =80 years provide the best value for money to prevent falls? A systematic review of economic evaluations of falls prevention interventions. Br J Sports Med 44:80–89PubMedCrossRef Davis JC, Robertson MC, Ashe MC, Liu-Ambrose T, Khan KM, Marra CA (2010) Does a home-based strength and balance programme in people aged > or =80 years provide the best value for money to prevent falls? A systematic review of economic evaluations of falls prevention interventions. Br J Sports Med 44:80–89PubMedCrossRef
31.
go back to reference Frick KD, Kung JY, Parrish JM, Narrett MJ (2010) Evaluating the cost-effectiveness of fall prevention programs that reduce fall-related hip fractures in older adults. J Am Geriatr Soc 58:136–141PubMedCrossRef Frick KD, Kung JY, Parrish JM, Narrett MJ (2010) Evaluating the cost-effectiveness of fall prevention programs that reduce fall-related hip fractures in older adults. J Am Geriatr Soc 58:136–141PubMedCrossRef
32.
go back to reference Parker MJ, Gillespie WJ, Gillespie LD (2009) Hip protectors for preventing hip fractures in older people. Cochrane Bone, Joint and Muscle Trauma Group. Cochrane Database of Systematic Reviews Parker MJ, Gillespie WJ, Gillespie LD (2009) Hip protectors for preventing hip fractures in older people. Cochrane Bone, Joint and Muscle Trauma Group. Cochrane Database of Systematic Reviews
33.
go back to reference Chamberlayne R, Green B, Barer ML, Hertzman C, Lawrence WJ, Sheps SB (1998) Creating a population-based linked health database: a new resource for health services research. Can J Public Health 89:270–273PubMed Chamberlayne R, Green B, Barer ML, Hertzman C, Lawrence WJ, Sheps SB (1998) Creating a population-based linked health database: a new resource for health services research. Can J Public Health 89:270–273PubMed
35.
go back to reference World Health Organization (1977) International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. World Health Organization, Geneva World Health Organization (1977) International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. World Health Organization, Geneva
36.
go back to reference Statistics Canada Health Division (1986) Canadian classification of diagnostic, therapeutic, and surgical procedures. Supply and Services, Ottawa Statistics Canada Health Division (1986) Canadian classification of diagnostic, therapeutic, and surgical procedures. Supply and Services, Ottawa
38.
go back to reference Statistics Canada (2007) Table 051-0001 Estimates of population, by age group and sex for July 1, Canada, provinces and territories, annual (persons), 1971 to 2007 (table). CANSIM (database). Using E-STAT (distributor) Statistics Canada (2007) Table 051-0001 Estimates of population, by age group and sex for July 1, Canada, provinces and territories, annual (persons), 1971 to 2007 (table). CANSIM (database). Using E-STAT (distributor)
41.
go back to reference Statistics Canada (2007) Population and Family Estimation Methods at Statistics Canada. Statistics Canada Catalogue no. 91-528-XIE. Ottawa, Ontario, Canada Statistics Canada (2007) Population and Family Estimation Methods at Statistics Canada. Statistics Canada Catalogue no. 91-528-XIE. Ottawa, Ontario, Canada
42.
go back to reference Fleiss JL (1973) Statistical methods for rates and proportions. Wiley, New York Fleiss JL (1973) Statistical methods for rates and proportions. Wiley, New York
43.
go back to reference Frome EL, Checkoway H (1985) Epidemiologic programs for computers and calculators. Use of Poisson regression models in estimating incidence rates and ratios. Am J Epidemiol 121:309–323PubMed Frome EL, Checkoway H (1985) Epidemiologic programs for computers and calculators. Use of Poisson regression models in estimating incidence rates and ratios. Am J Epidemiol 121:309–323PubMed
44.
go back to reference Leslie WD, O’Donnell S, Jean S, Lagace C, Walsh P, Bancej C, Morin S, Hanley DA, Papaioannou A (2009) Trends in hip fracture rates in Canada. JAMA 302:883–889PubMedCrossRef Leslie WD, O’Donnell S, Jean S, Lagace C, Walsh P, Bancej C, Morin S, Hanley DA, Papaioannou A (2009) Trends in hip fracture rates in Canada. JAMA 302:883–889PubMedCrossRef
45.
go back to reference Egan M, Jaglal S, Byrne K, Wells J, Stolee P (2008) Factors associated with a second hip fracture: a systematic review. Clin Rehabil 22:272–282PubMedCrossRef Egan M, Jaglal S, Byrne K, Wells J, Stolee P (2008) Factors associated with a second hip fracture: a systematic review. Clin Rehabil 22:272–282PubMedCrossRef
46.
go back to reference Ryg J, Rejnmark L, Overgaard S, Brixen K, Vestergaard P (2009) Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169, 145 cases during 1977–2001. J Bone Miner Res 24:1299–1307PubMedCrossRef Ryg J, Rejnmark L, Overgaard S, Brixen K, Vestergaard P (2009) Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169, 145 cases during 1977–2001. J Bone Miner Res 24:1299–1307PubMedCrossRef
48.
go back to reference Carter ND, Khan KM, McKay HA, Petit MA, Waterman C, Heinonen A, Janssen PA, Donaldson MG, Mallinson A, Riddell L, Kruse K, Prior JC, Flicker L (2002) Community-based exercise program reduces risk factors for falls in 65- to 75-year-old women with osteoporosis: randomized controlled trial. CMAJ 167:997–1004PubMed Carter ND, Khan KM, McKay HA, Petit MA, Waterman C, Heinonen A, Janssen PA, Donaldson MG, Mallinson A, Riddell L, Kruse K, Prior JC, Flicker L (2002) Community-based exercise program reduces risk factors for falls in 65- to 75-year-old women with osteoporosis: randomized controlled trial. CMAJ 167:997–1004PubMed
49.
go back to reference Langley J, Samaranayaka A, Davie G, Campbell AJ (2010) Age, cohort and period effects on hip fracture incidence: analysis and predictions from New Zealand data 1974–2007. Osteoporos Int Langley J, Samaranayaka A, Davie G, Campbell AJ (2010) Age, cohort and period effects on hip fracture incidence: analysis and predictions from New Zealand data 1974–2007. Osteoporos Int
50.
go back to reference Keating JF, Robinson CM, Court-Brown CM, McQueen MM, Christie J (1993) The effect of complications after hip fracture on rehabilitation. J Bone Jt Surg Br 75:976 Keating JF, Robinson CM, Court-Brown CM, McQueen MM, Christie J (1993) The effect of complications after hip fracture on rehabilitation. J Bone Jt Surg Br 75:976
Metadata
Title
Changes in first hip fracture rates in British Columbia Canada, 1990–2004
Authors
K. A. Lefaivre
A. R. Levy
B. Sobolev
S. Y. Cheng
L. Kuramoto
P. Guy
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 11/2011
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-010-1488-7

Other articles of this Issue 11/2011

Osteoporosis International 11/2011 Go to the issue